Form D · Biotechnology
REGENTIS BIOMATERIALS LTD.
Herzliya, L3 · CIK 0001912966
Offering snapshot reported Jun 25, 2026 · SEC filing
- Reported sold
- $6.5M Offering amount: $6.5M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 17, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 25, 2026 | Initial | $6,500,000 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $455K
- Finders' fees
- $0
- Form D file number
- 021-588680
An offering of 1,844,543 ordinary shares, 12,600 pre-funded warrants and 1,857,143 ordinary warrants, at a purchase price of $3.50 per share and ordinary warrant and $3.4999 per pre-funded warrant and ordinary warrant.
The Placement Agent also received a $180,000 accountable expense reimbursement, a non-accountable expense allowance of $65,000 and 92,857 unregistered warrants to purchase ordinary shares.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| ThinkEquity LLC | 000020996 |
Source: Form D, filed Jun 25, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Susan Alpert | Director |
| Pini Ben Elazar | Director |
| Efraim Cohen Arazi | Director |
| Jeff Dykan | Director |
| Ehud Geller | Director, Executive |
| Ori Gon | Executive |
| Arie Gordashnikov | Executive |
| Galit Reske | Executive |
| Keith Valentine | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
60 Medinat Hayehudim Street
Herzliya, L3, 4676652
Herzliya, L3, 4676652